Lumpectomy Options
You may be able to keep your breast and feel good about it.
For many patients with early-stage breast cancer, lumpectomy is not just an option, it is the oncologically equivalent option to mastectomy. The question is not always whether to keep the breast. It is whether the lumpectomy can be done in a way that leaves the breast looking and feeling like yours. That is the difference between standard lumpectomy and oncoplastic lumpectomy. It's a difference worth understanding before you decide.
Understanding Your Options
Same cancer removal. Different approach to what's left behind.
Standard Lumpectomy
Removes the tumor and a margin of surrounding healthy tissue, then closes the wound with whatever tissue remains at the resection site. For small tumors in favorable locations, the cosmetic result is often acceptable. For larger tumors, centrally located tumors, or tumors in anatomically sensitive areas, standard lumpectomy frequently produces a visible deformity a divot, asymmetry, or distortion that persists after healing and is not correctable without a separate reconstructive procedure.
Oncoplastic Lumpectomy
Removes the tumor with the same oncologic goals (clear margins, complete excision) and simultaneously reshapes the remaining breast tissue to fill the defect and restore contour. The reshaping happens at the time of the cancer surgery itself, not weeks or months later. Depending on the technique, this may also include a symmetry procedure on the opposite breast to match the result. The patient wakes up with the cancer removed and the breast already restored in a single operation.
What the Evidence Says
Oncoplastic lumpectomy improves appearance. Not survival because survival was already equivalent.
This distinction matters and deserves to be stated directly.
Oncoplastic lumpectomy does not improve cancer survival compared to standard lumpectomy. Neither does standard lumpectomy improve survival compared to oncoplastic lumpectomy. The reason: for most early-stage breast cancers, lumpectomy followed by radiation already produces equivalent long-term survival to mastectomy. The oncologic foundation of both approaches (complete tumor removal with clear margins) is the same. What oncoplastic surgery improves is the aesthetic outcome of that oncologically sound operation.
Where oncoplastic techniques do show measurable clinical benefit beyond appearance: studies consistently show lower re-excision rates with oncoplastic lumpectomy compared to standard lumpectomy. Re-excision — a return to the operating room because margins were not clear — occurs in approximately 20-25% of standard lumpectomy cases in published series. Oncoplastic techniques, which allow wider resection with better tissue handling and margin assessment, are associated with meaningfully lower re-excision rates. Fewer re-operations means fewer delays to adjuvant treatment, less anesthesia exposure, and less patient burden in addition to a better-looking result.
The Mastectomy Fear Connection
The fear of how the breast will look is driving women toward mastectomy and it doesn't have to
Many patients with early-stage breast cancer who are excellent lumpectomy candidates from a pure oncologic standpoint choose mastectomy because they are afraid of what lumpectomy will do to their appearance. They have seen or heard about deformities. They assume that keeping the breast means accepting a compromised result. And rather than live with a breast that looks wrong, they choose to remove it entirely.
This is a legitimate response to a real concern. But it is frequently a decision made without knowing that oncoplastic lumpectomy exists and that for many of these patients, breast conservation with an excellent cosmetic outcome is entirely achievable.
The goal of this guide is not to push any patient toward lumpectomy. Mastectomy is the right answer for some patients, and the decision to have one should be respected. But no patient should choose mastectomy because they didn't know their lumpectomy could look good. That is a decision made on incomplete information and it is the information Dr. Palakodeti makes sure every patient has before they decide.
Factors That Influence the Decision
Which approach fits your situation
Oncoplastic lumpectomy may be right if:
- Tumor size, location, or the resection volume required would produce a visible deformity with standard closure
- Breast volume is sufficient to allow reshaping after resection
- The tumor is in an aesthetically sensitive location — lower pole, central, near the areola
- You are a lumpectomy candidate who has concerns about the cosmetic result
- A contralateral symmetry procedure would improve overall balance
Standard lumpectomy may be appropriate if:
- The tumor is small relative to breast volume and in a favorable location where standard closure produces an acceptable result
- The patient and surgeon are confident the cosmetic outcome of standard lumpectomy will be satisfactory
- Anatomy or other clinical factors do not require reshaping
When mastectomy remains the right answer:
- Tumor size, extent of disease, or patient preference makes mastectomy the appropriate choice regardless of oncoplastic availability
- Oncoplastic lumpectomy is a tool that expands what is possible within breast conservation, it does not make every patient a conservation candidate
Why Dr. Palakodeti
The surgeon who trained to do both — so you don't have to choose
Standard lumpectomy is performed by general surgeons. Breast reshaping and contour restoration are performed by cosmetic surgeons. Oncoplastic lumpectomy requires both and most surgeons have training in only one.
Dr. Palakodeti's dual board certification in general surgery and cosmetic surgery means he performs the tumor removal and the reshaping as one integrated plan, in one operation, by one surgeon. The incision is placed with the cosmetic result already in mind. The resection is performed to oncologic standards. The reshaping is executed with the same technical rigor applied in a dedicated cosmetic practice. There is no second surgeon, no second operation, no aesthetic afterthought.
For patients who need a contralateral symmetry procedure, a reduction, lift, or augmentation of the opposite breast to match is performed in the same sitting as well. One anesthesia. One recovery. One complete result.
The Patient Journey
From consultation through recovery
The consultation
Dr. Palakodeti evaluates whether oncoplastic lumpectomy is feasible based on tumor size, location, and breast anatomy. If oncoplastic techniques are appropriate, the specific reshaping plan, which technique, whether a contralateral symmetry procedure is indicated, what the expected result looks like, is discussed at the first appointment. You leave with a complete surgical plan, not a preliminary conversation.
The operation
Oncoplastic lumpectomy is performed as a single outpatient procedure. Operative time is longer than standard lumpectomy given the additional reshaping component, but most patients go home the same day. The specimen is sent for pathology and margins are confirmed on final analysis typically within five to seven business days.
If margins are positive
If final pathology shows positive margins, re-excision may be necessary. Oncoplastic planning and tissue handling are associated with lower re-excision rates than standard lumpectomy, but it is not a guarantee, and this possibility is discussed before surgery.
Recovery
Recovery from oncoplastic lumpectomy is comparable to standard lumpectomy. Most patients return to light activity within one to two weeks. A supportive bra is worn throughout early recovery. Post-operative appointments are scheduled within the first week to two weeks.
"I've had patients come in who were told they needed a mastectomy. I've had patients come in who were offered a lumpectomy but chose mastectomy because they were afraid of how the breast would look. In both groups, there are patients who didn't need to make that trade-off — because oncoplastic lumpe
Sarath Palakodeti DO FACS FAACS
Frequently Asked Questions
Please reach us at contact@drpalakodeti.com if you cannot find an answer to your question.
No. And that's actually the most important thing to understand. Oncoplastic lumpectomy improves the cosmetic outcome of lumpectomy. It does not improve survival compared to standard lumpectomy. Both approaches share the same oncologic foundation: complete tumor removal with clear margins followed by radiation. The survival data for lumpectomy versus mastectomy which shows equivalence for most early-stage cancers applies to both. What oncoplastic techniques measurably improve beyond appearance is re-excision rates, which have real clinical value in reducing the need for additional surgery.
A re-excision is a return to the operating room to remove additional tissue when the first lumpectomy does not achieve clear margins on final pathology. It occurs in roughly 20-25% of standard lumpectomy cases in published data. Re-excision delays the start of radiation and adjuvant treatment, adds another anesthesia exposure, increases the risk of a poor cosmetic outcome, and adds burden to the patient's recovery. Oncoplastic techniques which allow wider resection and better tissue handling, are associated with meaningfully lower re-excision rates. Fewer re-operations is a clinical benefit independent of appearance.
The goal is a result that looks natural not necessarily identical to before surgery. Swelling resolves over weeks to months, and the final result takes time to emerge. Scar maturation continues for up to a year. For most patients, the result is significantly better than standard lumpectomy would have produced and allows them to feel comfortable in their own body during and after treatment. Perfection is not the promise — meaningful improvement over the alternative is.
A procedure on the opposite, non-cancer breast a reduction, lift, or augmentation performed at the same time as the oncoplastic lumpectomy to improve overall symmetry. It is not always necessary, but when the reshaping of the treated breast changes its size or position meaningfully, a symmetry procedure produces a balanced result that would not otherwise be achievable. Insurance coverage for symmetry procedures following breast cancer surgery is federally mandated under the Women's Health and Cancer Rights Act for mastectomy coverage after lumpectomy varies by plan and is worth verifying before surgery.
Breast volume affects what is technically achievable with reshaping techniques. Patients with smaller breasts have less tissue available for redistribution after resection which may limit the oncoplastic options or make mastectomy the more appropriate choice depending on the volume of tissue that needs to be removed. This is evaluated individually at your consultation. Oncoplastic technique selection is anatomy-driven, not a one-size-fits-all approach.
Secondary oncoplastic correction reshaping after a prior lumpectomy that produced a poor cosmetic result is possible in some cases. Feasibility depends on the extent of the deformity, the tissue that remains, and whether radiation has been completed. This is evaluated individually at consultation.
Printable Decision Guide
Bring This With You
A condensed version of this guide including the questions to ask your surgeon and space to write your own notes is available as a printable PDF.
Schedule a Consultation
The right decision is the one made with complete information
Dr. Palakodeti's practice serves patients across the South Central Kentucky and Northern Tennessee region. Newly diagnosed patients are prioritized for prompt scheduling.
484 Golden Autumn Way suite 201, Bowling Green, KY, USA
Hours
Today | Closed |
Copyright © 2026 Dr. Sarath Palakodeti - All Rights Reserved.